| P2093 | author name string | Christine Wagner | |
| | Gaurav Pathria | |
| | Stephan N Wagner | |
| P2860 | cites work | ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas | Q24290531 |
| | Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma | Q24597152 |
| | Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation | Q24629474 |
| | Rewired ERK-JNK signaling pathways in melanoma | Q24683737 |
| | Inhibition of Mutated, Activated BRAF in Metastatic Melanoma | Q27860458 |
| | Genomic analysis of metastasis reveals an essential role for RhoC | Q28144278 |
| | The mammalian Mog1 protein is a guanine nucleotide release factor for Ran | Q28144428 |
| | Identification of a signal for rapid export of proteins from the nucleus | Q29547742 |
| | Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma | Q29614282 |
| | Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K | Q29614757 |
| | Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA | Q29620175 |
| | The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain | Q29620270 |
| | A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking | Q33890625 |
| | PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells | Q33945648 |
| | NESbase version 1.0: a database of nuclear export signals | Q34169526 |
| | CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity | Q34207970 |
| | Nucleocytoplasmic transport: Ran, beta and beyond | Q34446326 |
| | Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer | Q34756429 |
| | Nuclear transport and cancer: from mechanism to intervention | Q35633427 |
| | The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions | Q36360691 |
| | Identification of nuclear export inhibitors with potent anticancer activity in vivo | Q37081966 |
| | CRM1-mediated nuclear export of proteins and drug resistance in cancer | Q37320237 |
| | Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases | Q37375070 |
| | Mdm2-mediated ubiquitylation: p53 and beyond. | Q37508606 |
| | ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence | Q37618297 |
| | Polo-like kinase 1 is a potential therapeutic target in human melanoma | Q39528323 |
| | Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6 | Q39576878 |
| | Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. | Q40005196 |
| | Recurrent patterns of dual RB and p53 pathway inactivation in melanoma | Q40340097 |
| | Subcellular localization determines the protective effects of activated ERK2 against distinct apoptogenic stimuli in myeloid leukemia cells. | Q40549982 |
| | Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line | Q40675789 |
| | Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism | Q40895714 |
| | Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin B. | Q40911261 |
| | Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma | Q40912648 |
| | Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis. | Q42066929 |
| | Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. | Q42650781 |
| | Involvement of protein phosphatase 2A nuclear accumulation and subsequent inactivation of activator protein-1 in leptomycin B-inhibited cyclin D1 expression | Q42796003 |
| | Anticancer therapy: boosting the bang of Bim. | Q43252624 |
| | Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal | Q45300833 |
| | Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis. | Q45941482 |
| | Cytoplasmic retention of peroxide-activated ERK provides survival in primary cultures of rat hepatocytes. | Q46552226 |
| | The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. | Q46668855 |
| | Sef is a spatial regulator for Ras/MAP kinase signaling | Q47235238 |
| | Fisetin: a natural fist against melanoma? | Q48872219 |
| | hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways. | Q53581949 |
| | Nuclear export is essential for the tumor-promoting activity of survivin. | Q53588764 |
| | RSK and MSK in MAP kinase signalling | Q58328419 |
| | Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation | Q58376144 |
| | A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals | Q73598439 |
| | CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin | Q77851227 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2780-2790 | |
| P577 | publication date | 2012-07-26 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways | |
| P478 | volume | 132 | |